Hemorrhagic Diathesis



Immune thrombocytopenic purpura (ITP)
          Also called idiopathic thrombocytopenic purpura
          Autoimmune disorder with production of anti-platelet antibody causing destruction of platelet
        Primary or idiopathic( absence of any known risk factors )
        Secondary
          Primary
        Acute
        Chronic- more common
          Secondary
        Systemic lupus erythematosus  
        AIDS
        After viral infection
        drug therapy
Chronic ITP
          Adult women younger than age 40 years
          F:M= 3:1
          Insidious onset
          Bleeding into skin and mucosal surfaces
          Petechiae, ecchymoses
          H/O nosebleeds, bleeding from gums, hemorrhage into soft tissues from minor trauma
           May present with melena, hematuria or excessive menstrual flow
           Subarachnoid hemorrhage and intracerebral hemorrhage: Serious consequences
Pathogenesis
          Chronic ITP caused by formation of autoantibodies against platelet membrane glycoproteins, most often IIb-IIIa or Ib-IX
          Antiplatelet antibodies are of the IgG class
          Opsonized platelets susceptible to phagocytosis by the cells of mononuclear phagocyte system
          Destruction of platelets

          Thrombocytopenia
Morphology
          Spleen: Normal in size
          Bone marrow
        Increased number of megakaryocytes
        Immature with large nonlobulated single nuclei
        Due to accelerated thrombopoiesis
        Important to rule out thrombocytopenia resulting from bone marrow failure
Diagnosis
          Prolonged bleeding time
          Normal clotting time, PT, APTT
          Low platelet count
          Normal or high megakaryocytes in bone marrow
          Abnormally large platelets (megathrombocytes) in blood smear
          Diagnosis of ITP should be made only after other causes of platelet deficiencies have been ruled out.
Acute immune thrombocytopenic purpura
          Disease of childhood occuring with equal frequency in both sexes
          Caused by antiplatelet antibody
          Abrupt onset
          Preceded by viral illness (2 wks)
          Self limited, usually resolving spontaneously within 6 months
Hemophilia A (Factor VIII deficiency)
Ø  Most common hereditary disease associated with serious bleeding
Ø  Caused by reduction in the amount or activity of factor VIII
Ø  X-linked recessive trait; males affected
Ø  Heterozygous females, presumably as a result of lyonization (inactivation of the normal X chromosome in most of the cells
Clinical severity according to level of factor VIII activity
  <1% of normal activity- Severe disease
  2-5%: Moderate disease
  6-50%: Mild disease
30% new mutation, remaining positive family history
Clinical features
Ø  Easy bruising (discoloured skin caused by injury on blood vessels)
Ø   Massive hemorrhage after trauma or operative procedures
Ø  Spontaneous hemorrhage into joints- Hemarthroses
Ø  Deformities
Ø  Petechiae are characteristically absent
Investigation
          Normal BT, PT and platelet count
          Prolonged PTT; Abnormality of intrinsic coagulation pathway
          Factor VIII assay
          Treatment involves infusion of factor VIII
Hemophilia B (Christmas disease, Factor IX deficiency)
Ø   Clinically indistinguishable from factor VIII deficiency (hemophilia A)
Ø  Caused by mutation in factor IX
Ø   X-linked recessive
Ø   PTT prolonged
Ø   BT, PT normal
Ø   Factor IX assay
Disseminated intravascular coagulation (DIC)
          Acute, subacute or chronic thrombohemorrhagic disorders occurring as a secondary complication in a variety of diseases
          Systemic activation of coagulation pathway
          Formation of microthrombi through out the microcirculation 
          Consumption of platelet, fibrin, and clotting factors- “consumption coagulopathy”
          Activation of fibrinolytic mechanism
          Microthrombi à  tissue hypoxia and microinfarcts
           Pathologic activation of fibrinolysis and the depletion of the elements required for hemostasis à Bleeding disorder
          Consumptive coagulopathy
Major disorders associated with DIC
1.       Obstetric complications
a.       Abruptio placentae
b.      Retained dead fetus
c.       Septic abortion
d.      Amniotic fluid embolism
e.      Toxemia
2.       Infections
a.       Gram negative sepsis
b.      Meningococcemia
c.       Histoplasmosis
d.      Aspergillosis
e.      Malaria
3.       Neoplasms
a.       Carcinomas of pancreas, prostate, lung and stomach
b.      Acute promyelocytic leukemia
4.       Massive tissue injury
a.       Traumatic
b.      Burns
c.       Extensive surgery
5.       Miscellaneous: Acute intravascular hemolysis, snake bite, shock

Most important
        Obstetric complications
        Malignant neoplasia
        Sepsis
        Major trauma
Pathogenesis
          Two major mechanisms trigger DIC:
        Release of tissue factor  or thromboplastic substances into circulation
        Widespread injury to endothelial cells
          Obstetric complications
        Tissue thromboplastin released from placental tissue ,dead retained fetus or amniotic fluid enter circulation
        Endothelial injury caused by hypoxia, acidosis and shock
          Malignancies
        Tissue thromboplastin derived from granules of leukemic cells
        Mucus released from adenoca directly activate factor X independent of factor VII
          Sepsis
        Activate both intrinsic and extrinsic pathways
        Bacterial endotoxin cause activated monocytes to release TNF and IL-1 à Both increase expression of tissue factor on endothelial cells
        TNF causes endothelial cell inflammation and injury
        Endotoxin inhibit anticoagulant activity of protein C by supressing thrombomodulin expression on endothelium
          Widespread endothelial injury produced by
        Antigen-antibody complexes : SLE
        Temperature extremes: heat stroke, burn
        Microorganisms: meningococci, rickettsiae
          Massive trauma, severe burn, extensive surgery
        Release of tissue thromboplastin
          Endothelial injury
        Release tissue factor
        Promote platelet aggregation
        Activate intrinsic coagulation pathway (activation of factor XII by surface contact with collagen or other negatively charged substances)
Consequences of DIC
Widespread deposition of fibrin within microcirculation
    1. Tissue ischemia
    2. Microangiopathic hemolytic anemia
Hemorrhagic diathesis
    1. Consumption of platelet and clotting factors with activation of plasminogen
    2. Plasmin cleave fibrin, digest factors V and VIII
    3. Fibrinolysis leads to formation of fibrin degradation products, which inhibit platelet aggregation, fibrin polymerization and have antithrombin activity
Causes of DIC
Activation of extrinsic/intrinsic coagulation pathways
                                                Thrombin
Fibrinogen          Fibrin     Fibrin clot
                                                                Plasmin
                                                Fibrin degradation products (FDP)
                                                                                Bleeding
                                               
Morphology
          Thrombi found in following sites:
        Brain, heart, lungs, kidneys, adrenals, spleen, and liver
        Lungs: fibrin thrombi in alveolar capillaries with pulmonary edema and fibrin exudation  creating hyaline membrane
        Kidney: thrombi in glomeruli that evoke reactive swelling of swelling of endothelial cells; in severe cases-microinfarcts, bilateral renal cortical necrosis
        In CNS thrombi may cause microinfarct
        Endocrine glands
          Microthrombi within microcirculation of adrenal cortex in  meningococcemia- Waterhouse-Friderichsen Syndrome (massive adrenal hemorrhage)
          Sheehan postpartum pituitary necrosis
Clinical features
           Two main features of DIC:
        Bleeding
        Organ damage due to ischemia
          Acute DIC associated with obstetric complications, endotoxic shock or major trauma: Bleeding
          Chronic DIC (carcinoma, retention of dead fetus): Thrombotic complications
          Abrupt onset of bleeding
          Microangiopathic hemolytic anemia
          Dyspnea
          Cyanosis
          Respiratory failure
          Convulsion and coma
          Oliguria, acute renal failure
          Progressive circulatory failure, shock
Laboratory findings
  1. Thrombocytopenia
  2. PT, PTT,BT,CT,TT all prolonged
  3. FDP +, D-Dimer +
  4. Plasma fibrinogen decreased
  5. Thrombin time (TT)  increased
  6. P/S- Fragmented RBC
          Prognosis depends on underlying disorder
          Remove or treat the underlying cause

Comments

  1. I was born with HIV my mother passed away because of the HIV infection And I regret why i never met Dr Itua he could have cured my mum for me because as a single mother it was very hard for my mother I came across Dr itua healing words online about how he cure different disease in different races diseases like HIV/Aids Herpes,Parkison,Asthma,Autism,Copd,Epilepsy,Shingles,Cold Sore,Infertility, Chronic Fatigues Syndrome, Lupus Cure,Fibromyalgia,Cancer,Alzheimer's disease,psoriasis,Bipolar Disorder,Dementia Disease,Chronic Diarrhea,Ataxia,Arthritis,Amyotrophic Lateral Sclerosis,Stroke,Fibromyalgia,Weak Erection,Breast Enlargment,Penis Enlargment,Hpv,measles, tetanus, whooping cough, tuberculosis, polio and diphtheria)Diabetes Hepatitis,I was so excited but frighten at same time because I haven't come across such thing article online then I contacted Dr Itua on Mail drituaherbalcenter@gmail.com/www.drituaherbalcenter.com . I also chat with him he tells me how it works then I tell him I want to proceed I paid him so swiftly Colorado post office I receive my herbal medicine within 4/5 working days he gave me guidelines to follow and here am I living healthy again can imagine how god use men to manifest his works am I writing in all articles online to spread the god work of Dr Itua Herbal Medicine.

    ReplyDelete

Post a Comment

Popular posts from this blog

Separating Medium

Chemical Stages of Polymerization of Acrylic Resin

Manipulation of Gypsum Product